J Verweij, J H Schellens. Show Affiliations »
Abstract
Mesh: See more » Antineoplastic Agents, Phytogenic/administration & dosageAntineoplastic Agents, Phytogenic/pharmacologyAntineoplastic Agents, Phytogenic/therapeutic useCamptothecin/administration & dosageCamptothecin/analogs & derivativesCamptothecin/pharmacologyCamptothecin/therapeutic useClinical Trials, Phase I as TopicDrug DesignDrug SynergismHumansIrinotecanNeoplasm Proteins/antagonists & inhibitorsNeoplasms/drug therapyNeoplasms/enzymologyTopoisomerase I InhibitorsTopotecan
Substances: See more » Antineoplastic Agents, PhytogenicNeoplasm ProteinsTopoisomerase I InhibitorsIrinotecanTopotecanCamptothecin
Year: 1995 PMID: 7786815 DOI: 10.1093/oxfordjournals.annonc.a059100
Source DB: PubMed Journal: Ann Oncol ISSN: 0923-7534 Impact factor: 32.976